How to evaluate a peptide supplier.

The research peptide market is unregulated by design — “research use only” means there’s no FDA inspecting the manufacturer. The burden of quality falls entirely on the supplier and, by extension, on the buyer’s ability to evaluate one. Here are the five non-negotiables.

1. Purity ≥99% by HPLC

High-Performance Liquid Chromatography (HPLC) separates the peptide from impurities and quantifies how much of the final product is actually the target sequence. ≥99% is the pharmaceutical-grade benchmark. Anything below that is research-grade in name only.

2. A Certificate of Analysis (COA) per batch

A COA is the lab report for that specific batch — purity, mass spec confirmation of the correct molecular weight, and physical characteristics. If a supplier can’t produce a COA tied to the batch number on your vial, you have no evidence of what you bought.

3. Independent third-party testing

Internal QC is necessary but not sufficient — manufacturers grading their own homework is a known failure mode in unregulated markets. A serious supplier sends every batch to an independent, accredited laboratory for orthogonal verification.

4. GMP-compliant manufacturing

Good Manufacturing Practice (GMP) is the framework that governs pharmaceutical-grade production: documented processes, controlled environments, traceability, and cross-contamination controls. GMP-aligned facilities cost more to operate — that’s the point.

5. Mechanism-first education

This one is softer but no less important. A supplier that explains how a peptide works — the receptor, the pathway, the actual biology — is signaling that they understand the molecule and respect the reader. A supplier that only lists benefits and dosages is signaling something else.